Kusafuka K, Hiraki Y, Shukunami C, Yamaguchi A, Kayano T, Takemura T
Department of Pathology, Japanese Red Cross Medical Center, 4-1-22 Hiroo, Shibuya-ku, Tokyo 150-8935, Japan.
Am J Pathol. 2001 Apr;158(4):1465-72. doi: 10.1016/S0002-9440(10)64097-7.
Chondromodulin-I (ChM-I) is a novel cartilage-specific matrix protein. In the growth plates of the long bones, ChM-I was shown to be expressed in mature to upper hypertrophic chondrocytes, and to be deposited in the cartilage matrix. As ChM-I strongly inhibits angiogenesis, cartilage is avascular. Also, ChM-I has bifunctional activity against chondrocyte proliferation. On the other hand, pleomorphic adenomas of the salivary glands frequently have chondroid elements. To elucidate the relationship between chondroid formation and hypovascularity in salivary pleomorphic adenomas, we immunohistochemically examined the expression and localization of ChM-I in 35 cases of this tumor. ChM-I was immunolocalized to the lacunae in the chondroid elements of pleomorphic adenomas (100%). Type II collagen and aggrecan were immunolocalized throughout the matrix around lacuna cells of the chondroid element (100%, 91.7%), and ChM-I was infrequently immunolocalized to the spindle-shaped myoepithelial cells in the myxoid element (37.5%). Fibroblast growth factor-2 was strongly immunolocalized to the lacuna cells in the chondroid element (100%), among the neoplastic myoepithelial cells in the myxoid elements (96.9%), and on the basement membranes around the solid nests of neoplastic myoepithelial cells (71.4%). Although CD34 is a marker of endothelial cells, CD34 was expressed in the endothelial cells in only a few areas around the epithelial elements and in the fibrous element of pleomorphic adenomas. No signals for CD34 were observed in chondroid elements in pleomorphic adenomas (P < 0.001), but a few signals were seen in the myxoid elements (P < 0.05). These findings suggested that lacuna cells and neoplastic myoepithelial cells expressed ChM-I, and that this molecule may play an important role in hypovascularity and chondroid differentiation in pleomorphic adenoma. In conclusion, pleomorphic adenoma expressed ChM-I, which is involved in hypovascularity and chondroid formation in this type of tumor.
软骨调节素-I(ChM-I)是一种新型的软骨特异性基质蛋白。在长骨的生长板中,ChM-I在成熟至上层肥大软骨细胞中表达,并沉积于软骨基质中。由于ChM-I强烈抑制血管生成,软骨是无血管的。此外,ChM-I对软骨细胞增殖具有双功能活性。另一方面,涎腺多形性腺瘤常含有软骨样成分。为了阐明涎腺多形性腺瘤中软骨样形成与血管减少之间的关系,我们对35例该肿瘤进行了ChM-I表达和定位的免疫组织化学检查。ChM-I免疫定位在多形性腺瘤软骨样成分的腔隙中(100%)。II型胶原蛋白和聚集蛋白聚糖免疫定位在软骨样成分腔隙细胞周围的整个基质中(100%,91.7%),而ChM-I很少免疫定位在黏液样成分中的梭形肌上皮细胞中(37.5%)。成纤维细胞生长因子-2强烈免疫定位在软骨样成分的腔隙细胞中(100%)、黏液样成分的肿瘤性肌上皮细胞中(96.9%)以及肿瘤性肌上皮细胞实性巢周围的基底膜上(71.4%)。虽然CD34是内皮细胞的标志物,但CD34仅在多形性腺瘤上皮成分周围的少数区域以及纤维成分中的内皮细胞中表达。在多形性腺瘤的软骨样成分中未观察到CD34信号(P<0.001),但在黏液样成分中可见少数信号(P<0.05)。这些发现表明腔隙细胞和肿瘤性肌上皮细胞表达ChM-I,并且该分子可能在多形性腺瘤的血管减少和软骨样分化中起重要作用。总之,多形性腺瘤表达ChM-I,其参与了这类肿瘤的血管减少和软骨样形成。